Evidence map›Paper›PMID 28703806›Full record

ArticleCell death & disease2017

Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.

Hendrik Folkerts, Susan Hilgendorf, Albertus T J Wierenga, Jennifer Jaques, André B Mulder, Paul J Coffer, Jan Jacob Schuringa, Edo Vellenga

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Pandora's Box of AML: HowBiomedicines · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Frontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hendrik FolkertsDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Susan HilgendorfDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Albertus T J WierengaDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Jennifer JaquesDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
André B MulderDepartment of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Paul J CofferRegenerative Medicine Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Jan Jacob SchuringaDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-8452-8555
Edo VellengaDepartment of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we have explored whether inhibition of autophagy can be used as a treatment strategy for acute myeloid leukemia (AML). Steady-state autophagy was measured in leukemic cell lines and primary human CD34

Indexed as

AutophagyAnimalsAntigens, CD34ApoptosisApoptosis Regulatory ProteinsAutophagy-Related Protein 5Autophagy-Related Protein 7bcl-2-Associated X ProteinBone Marrow CellsCell Line, TumorFemaleHumansHydroxychloroquineLeukemia, Myeloid, AcuteMiceMice, Inbred NODAntigens, CD34Apoptosis Regulatory ProteinsAutophagy-Related Protein 5Autophagy-Related Protein 7BBC3 protein, humanbcl-2-Associated X ProteinHydroxychloroquineProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID28703806
PMCPMC5550863
OpenAlexW2735492323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.